US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dianthus Therapeutics Inc.

35.61

+0.03500.10%

Volume:1.38M

Turnover:49.05M

Market Cap:1.15B

PE:-10.96

High:36.99

Open:33.80

Low:33.50

Close:35.57

52wk High:36.99

52wk Low:13.37

Shares:32.19M

Float Shares:13.46M

Volume Ratio:2.17

T/O Rate:10.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.2490

EPS(LYR):-2.5506

ROE:-34.71%

ROA:-23.37%

PB:3.78

PE(LYR):-13.96

Loading ...

Overview Company News Filings

BRIEF-Dianthus Therapeutics Announces Pricing Of Upsized $251 Million Underwritten Public Offering

BUZZ-Dianthus Therapeutics surges again ahead of planned equity raise

Dianthus Therapeutics Is Maintained at Outperform by Baird

Dianthus price target raised to $67 from $50 at Baird

Dianthus announces $150M common stock offering

Dianthus Therapeutics Inc. Announces $150 Million Underwritten Public Offering to Advance Antibody Therapeutics Development

Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering

THOMSON REUTERS

Dianthus Shares Whipsaw on Strong Trial Results, Safety Concerns

BUZZ-U.S. STOCKS ON THE MOVE-Sanofi SA, Nutanix, Bullish

Dianthus Therapeutics Shares Reverse Course, Last up 19.3% After Mid-Stage Trial Data for Its Muscle-Weakening Drug

THOMSON REUTERS

Evercore ISI Adjusts Dianthus Therapeutics Price Target to $72 From $50, Maintains Outperform Rating

MT Newswires Live

Dianthus price target raised to $72 at Evercore after ‘bull case outcome’

Dianthus Therapeutics Shares Reverse Premarket Gains, Last Down 13.2%

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-Veeva, Gold miners, Ideaya Biosciences

BUZZ-Dianthus Therapeutics rises after mid-stage trial win for muscle-weakening drug

Dianthus announces data from Phase 2 MaGic trial of claseprubart

Dianthus Therapeutics Inc - Claseprubart Shows Favorable Safety Profile

THOMSON REUTERS

Dianthus Therapeutics Inc - Phase 3 Gmg Trial for Claseprubart Anticipated to Start in 2026

THOMSON REUTERS

Dianthus Therapeutics Inc. Announces Phase 2 MaGic Trial Results for Claseprubart (DNTH103) in Generalized Myasthenia Gravis

Dianthus Therapeutics (DNTH) Gets a Buy from Guggenheim

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DNTH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DNTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DNTH\",,,,,undefined,":{"symbol":"DNTH","market":"US","secType":"STK","nameCN":"Dianthus Therapeutics Inc.","latestPrice":35.605,"timestamp":1757518848010,"preClose":35.57,"halted":0,"volume":1383087,"delay":0,"floatShares":13459144,"shares":32188345,"eps":-3.249007,"marketStatus":"Trading","change":0.035,"latestTime":"09-10 11:41:07 EDT","open":33.8,"high":36.99,"low":33.4979,"amount":49054250.908139996,"amplitude":0.098175,"askPrice":35.8,"askSize":106,"bidPrice":35.44,"bidSize":150,"shortable":3,"etf":0,"ttmEps":-3.249007,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1757534400000},"marketStatusCode":2,"adr":0,"listingDate":1529553600000,"exchange":"NASDAQ","adjPreClose":35.57,"preHourTrading":{"tag":"盘前","latestPrice":33.79,"preClose":35.57,"latestTime":"09:29 EDT","volume":67218,"amount":2404566.32379,"timestamp":1757510968068},"postHourTrading":{"tag":"盘后","latestPrice":35.7,"preClose":35.57,"latestTime":"19:59 EDT","volume":46425,"amount":1651865.4842,"timestamp":1757462343032},"volumeRatio":2.171703,"impliedVol":0.7009,"impliedVolPercentile":0.492},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DNTH\",,,,,undefined,":{"symbol":"DNTH","floatShares":13459144,"roa":"-23.37%","roe":"-34.71%","lyrEps":-2.55056,"volumeRatio":2.171703,"shares":32188345,"dividePrice":0,"high":36.99,"amplitude":0.098175,"preClose":35.57,"low":33.4979,"week52Low":13.365,"pbRate":"3.78","psRate":"236.11","week52High":36.99,"institutionHeld":0,"latestPrice":35.605,"committee":0.171875,"eps":-3.249007,"divideRate":0,"volume":1383087,"delay":0,"ttmEps":-3.249007,"open":33.8,"prevYearClose":21.8,"prevWeekClose":26.5,"prevMonthClose":23.57,"prevQuarterClose":18.63,"fiveDayClose":24.26,"twentyDayClose":19.9,"sixtyDayClose":18.31},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DNTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-07","symbol":"DNTH","fiscalQuarterEnding":"2025/06","expectedEps":-0.86,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.88},{"market":"US","date":"2025-05-12","symbol":"DNTH","fiscalQuarterEnding":"2025/03","expectedEps":-0.86,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.82},{"market":"US","date":"2025-03-11","symbol":"DNTH","fiscalQuarterEnding":"2024/12","expectedEps":-0.85,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"post","actualEps":-0.81},{"market":"US","date":"2024-11-07","symbol":"DNTH","fiscalQuarterEnding":"2024/09","expectedEps":-0.59,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.74},{"market":"US","date":"2024-08-08","symbol":"DNTH","fiscalQuarterEnding":"2024/06","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"post","actualEps":-0.51}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DNTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DNTH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5385,"buy":0.4615,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5385,"analysts":13,"updateTime":1751515200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DNTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DNTH","date":"2025-09-09","current":-8.919858,"percent":0.537313,"low":-21.520733,"twenty":-14.830195,"median":-9.797719,"eighty":-5.774826,"high":-2.378652,"avg":-10.190222,"sd":4.58644,"marketCap":1023589371},"quantilePoints":[{"date":"2023-09-22","current":-6.821887,"twenty":-6.869759,"median":-6.842701,"eighty":-6.807317,"marketCap":194260047},{"date":"2023-09-29","current":-5.576152,"twenty":-6.838538,"median":-5.576152,"eighty":-5.435929,"marketCap":201460812},{"date":"2023-10-06","current":-4.920135,"twenty":-6.800032,"median":-5.4757,"eighty":-5.354747,"marketCap":177759540},{"date":"2023-10-13","current":-4.916034,"twenty":-6.077097,"median":-5.403948,"eighty":-4.942276,"marketCap":177611407},{"date":"2023-10-20","current":-5.11694,"twenty":-5.587632,"median":-5.309646,"eighty":-5.016077,"marketCap":184869921},{"date":"2023-10-27","current":-4.75613,"twenty":-5.576152,"median":-5.262494,"eighty":-4.957036,"marketCap":171834222},{"date":"2023-11-03","current":-4.920135,"twenty":-5.49415,"median":-5.12514,"eighty":-4.920135,"marketCap":177759540},{"date":"2023-11-10","current":-4.678228,"twenty":-5.457249,"median":-5.084139,"eighty":-4.879133,"marketCap":169019695},{"date":"2023-11-17","current":-3.935775,"twenty":-5.444949,"median":-4.957036,"eighty":-4.76023,"marketCap":169663374},{"date":"2023-11-24","current":-4.021709,"twenty":-5.412148,"median":-4.920135,"eighty":-4.674948,"marketCap":173367815},{"date":"2023-12-01","current":-3.842966,"twenty":-5.377707,"median":-4.920135,"eighty":-3.993522,"marketCap":165662579},{"date":"2023-12-08","current":-3.640162,"twenty":-5.338346,"median":-4.907834,"eighty":-3.949524,"marketCap":156920099},{"date":"2023-12-15","current":-2.684576,"twenty":-5.297345,"median":-4.846332,"eighty":-3.884902,"marketCap":115726721},{"date":"2023-12-22","current":-3.007688,"twenty":-5.267824,"median":-4.788931,"eighty":-3.85534,"marketCap":129655417},{"date":"2023-12-29","current":-3.482043,"twenty":-5.235843,"median":-4.75818,"eighty":-3.842966,"marketCap":150103929},{"date":"2024-01-05","current":-4.482315,"twenty":-5.235843,"median":-4.715129,"eighty":-3.861528,"marketCap":193223616},{"date":"2024-01-12","current":-4.05952,"twenty":-5.169421,"median":-4.670027,"eighty":-3.873902,"marketCap":174997769},{"date":"2024-01-19","current":-3.952961,"twenty":-5.12186,"median":-4.521845,"eighty":-3.879402,"marketCap":170404263},{"date":"2024-01-26","current":-6.135656,"twenty":-5.267824,"median":-4.661827,"eighty":-3.893152,"marketCap":264495873},{"date":"2024-02-02","current":-14.091886,"twenty":-5.428549,"median":-4.735629,"eighty":-3.901401,"marketCap":607473021},{"date":"2024-02-09","current":-15.77856,"twenty":-5.593373,"median":-4.788931,"eighty":-3.913775,"marketCap":680182147},{"date":"2024-02-16","current":-16.247836,"twenty":-6.141843,"median":-4.875033,"eighty":-3.933712,"marketCap":700411702},{"date":"2024-02-23","current":-16.322648,"twenty":-6.585949,"median":-4.911934,"eighty":-3.935775,"marketCap":703636704},{"date":"2024-03-01","current":-16.832731,"twenty":-6.855189,"median":-4.920135,"eighty":-3.939212,"marketCap":725625351},{"date":"2024-03-08","current":-17.220393,"twenty":-14.108208,"median":-4.920135,"eighty":-3.952961,"marketCap":742336722},{"date":"2024-03-15","current":-18.274564,"twenty":-15.869694,"median":-5.055438,"eighty":-3.952961,"marketCap":787779926},{"date":"2024-03-22","current":-19.002283,"twenty":-16.27504,"median":-5.103895,"eighty":-3.958461,"marketCap":819150396},{"date":"2024-03-28","current":-20.617859,"twenty":-16.390659,"median":-5.12104,"eighty":-3.98046,"marketCap":898010856},{"date":"2024-04-05","current":-16.662734,"twenty":-16.662734,"median":-5.235843,"eighty":-3.987335,"marketCap":725745374},{"date":"2024-04-12","current":-16.777278,"twenty":-16.777278,"median":-5.350646,"eighty":-3.990772,"marketCap":730734324},{"date":"2024-04-19","current":-15.922581,"twenty":-16.832731,"median":-5.444949,"eighty":-3.99421,"marketCap":693508032},{"date":"2024-04-26","current":-14.143673,"twenty":-16.777278,"median":-5.535151,"eighty":-4.021709,"marketCap":616027659},{"date":"2024-05-03","current":-16.178636,"twenty":-16.662734,"median":-5.637242,"eighty":-4.021709,"marketCap":704660510},{"date":"2024-05-10","current":-14.570862,"twenty":-16.662734,"median":-6.140812,"eighty":-4.049207,"marketCap":731661246},{"date":"2024-05-17","current":-15.342363,"twenty":-16.621896,"median":-6.530951,"eighty":-4.05952,"marketCap":770401432},{"date":"2024-05-24","current":-12.724299,"twenty":-16.45867,"median":-6.737265,"eighty":-4.100768,"marketCap":638937940},{"date":"2024-05-31","current":-12.098897,"twenty":-16.404261,"median":-6.842701,"eighty":-4.106268,"marketCap":607534008},{"date":"2024-06-07","current":-12.233329,"twenty":-16.390659,"median":-12.098897,"eighty":-4.121392,"marketCap":614284386},{"date":"2024-06-14","current":-15.75779,"twenty":-16.354335,"median":-12.233329,"eighty":-4.176389,"marketCap":791261684},{"date":"2024-06-21","current":-15.114854,"twenty":-16.327131,"median":-12.630781,"eighty":-4.296009,"marketCap":758977268},{"date":"2024-06-28","current":-14.565435,"twenty":-16.324142,"median":-12.706764,"eighty":-4.381256,"marketCap":731388767},{"date":"2024-07-05","current":-15.459702,"twenty":-16.325636,"median":-12.794437,"eighty":-4.452753,"marketCap":776293455},{"date":"2024-07-12","current":-16.932611,"twenty":-16.417863,"median":-13.066224,"eighty":-4.47819,"marketCap":850254116},{"date":"2024-07-15","current":-16.920921,"twenty":-16.466954,"median":-13.180199,"eighty":-4.480252,"marketCap":849667127},{"date":"2024-08-02","current":-16.371502,"twenty":-16.45867,"median":-13.180199,"eighty":-4.482315,"marketCap":822078626},{"date":"2024-08-09","current":-13.845994,"twenty":-16.50009,"median":-13.738229,"eighty":-4.561374,"marketCap":784804801},{"date":"2024-08-16","current":-15.438194,"twenty":-16.45867,"median":-13.792112,"eighty":-4.661827,"marketCap":875052279},{"date":"2024-08-23","current":-14.304023,"twenty":-16.390659,"median":-14.112289,"eighty":-4.678228,"marketCap":810766318},{"date":"2024-08-30","current":-14.899592,"twenty":-16.390659,"median":-14.219338,"eighty":-4.715129,"marketCap":844523786},{"date":"2024-09-06","current":-14.490462,"twenty":-16.375333,"median":-14.311791,"eighty":-4.74793,"marketCap":821333873},{"date":"2024-09-13","current":-14.402421,"twenty":-16.338396,"median":-14.319559,"eighty":-4.75941,"marketCap":816343639},{"date":"2024-09-20","current":-14.552608,"twenty":-16.324142,"median":-14.311791,"eighty":-4.783191,"marketCap":824856392},{"date":"2024-09-27","current":-13.993291,"twenty":-16.306326,"median":-14.304023,"eighty":-4.815172,"marketCap":793153726},{"date":"2024-10-04","current":-14.221161,"twenty":-16.285922,"median":-14.291076,"eighty":-4.861093,"marketCap":806069627},{"date":"2024-10-11","current":-14.672555,"twenty":-16.269355,"median":-14.319559,"eighty":-4.877493,"marketCap":831655088},{"date":"2024-10-18","current":-14.522306,"twenty":-16.254626,"median":-14.311791,"eighty":-4.902094,"marketCap":823138846},{"date":"2024-10-25","current":-14.475677,"twenty":-16.248614,"median":-14.360865,"eighty":-4.914394,"marketCap":820495874},{"date":"2024-10-31","current":-14.486039,"twenty":-16.239675,"median":-14.366036,"eighty":-4.918495,"marketCap":821083201},{"date":"2024-11-08","current":-13.087312,"twenty":-16.213004,"median":-14.381745,"eighty":-4.920135,"marketCap":878053924},{"date":"2024-11-15","current":-11.244659,"twenty":-16.189942,"median":-14.360865,"eighty":-4.920135,"marketCap":754426637},{"date":"2024-11-22","current":-8.941908,"twenty":-16.180782,"median":-14.311791,"eighty":-4.920135,"marketCap":599930480},{"date":"2024-11-29","current":-10.582949,"twenty":-16.17095,"median":-14.273283,"eighty":-4.920135,"marketCap":710031190},{"date":"2024-12-06","current":-10.437372,"twenty":-16.142849,"median":-14.241876,"eighty":-4.934895,"marketCap":700264191},{"date":"2024-12-13","current":-10.36679,"twenty":-16.097823,"median":-14.188265,"eighty":-4.996397,"marketCap":695528677},{"date":"2024-12-20","current":-10.163866,"twenty":-16.05809,"median":-14.112289,"eighty":-5.061998,"marketCap":681914073},{"date":"2024-12-27","current":-10.14622,"twenty":-16.019613,"median":-14.091886,"eighty":-5.076759,"marketCap":680730195},{"date":"2025-01-03","current":-10.234448,"twenty":-15.922581,"median":-13.957579,"eighty":-5.096439,"marketCap":686649588},{"date":"2025-01-10","current":-11.284361,"twenty":-15.89482,"median":-13.822388,"eighty":-5.108369,"marketCap":757090364},{"date":"2025-01-17","current":-8.474299,"twenty":-15.887478,"median":-13.728741,"eighty":-5.115822,"marketCap":568557697},{"date":"2025-01-24","current":-9.828599,"twenty":-15.834329,"median":-13.708453,"eighty":-5.12186,"marketCap":659420380},{"date":"2025-01-31","current":-9.603618,"twenty":-15.788231,"median":-13.553088,"eighty":-5.191562,"marketCap":644325928},{"date":"2025-02-07","current":-10.128574,"twenty":-15.779567,"median":-13.462457,"eighty":-5.235843,"marketCap":679546316},{"date":"2025-02-14","current":-10.644708,"twenty":-15.766098,"median":-13.180199,"eighty":-5.267824,"marketCap":714174765},{"date":"2025-02-21","current":-10.455018,"twenty":-15.745542,"median":-13.087312,"eighty":-5.305545,"marketCap":701448070},{"date":"2025-02-28","current":-9.285997,"twenty":-15.702913,"median":-12.81575,"eighty":-5.346546,"marketCap":623016113},{"date":"2025-03-07","current":-10.375613,"twenty":-15.663831,"median":-12.724299,"eighty":-5.384267,"marketCap":696120616},{"date":"2025-03-14","current":-8.045567,"twenty":-15.60664,"median":-12.588406,"eighty":-5.420348,"marketCap":683623809},{"date":"2025-03-21","current":-7.727979,"twenty":-15.500032,"median":-12.233329,"eighty":-5.449869,"marketCap":656638658},{"date":"2025-03-28","current":-7.512473,"twenty":-15.459702,"median":-12.013661,"eighty":-5.472009,"marketCap":638327306},{"date":"2025-04-04","current":-6.416037,"twenty":-15.451099,"median":-11.624039,"eighty":-5.526951,"marketCap":545164287},{"date":"2025-04-11","current":-5.898066,"twenty":-15.431979,"median":-11.290978,"eighty":-5.587632,"marketCap":501152792},{"date":"2025-04-17","current":-7.175981,"twenty":-15.413286,"median":-11.262304,"eighty":-5.60754,"marketCap":609735897},{"date":"2025-04-25","current":-8.026663,"twenty":-15.369114,"median":-11.0285,"eighty":-5.622077,"marketCap":682017550},{"date":"2025-05-02","current":-8.204554,"twenty":-15.321347,"median":-10.898364,"eighty":-5.689407,"marketCap":697132746},{"date":"2025-05-09","current":-7.796217,"twenty":-15.230244,"median":-10.759405,"eighty":-5.898822,"marketCap":662436738},{"date":"2025-05-16","current":-5.986178,"twenty":-15.201008,"median":-10.704262,"eighty":-5.916298,"marketCap":602999662},{"date":"2025-05-23","current":-5.861665,"twenty":-15.193619,"median":-10.675588,"eighty":-5.916298,"marketCap":590457269},{"date":"2025-05-30","current":-5.698841,"twenty":-15.181369,"median":-10.600594,"eighty":-5.861665,"marketCap":574055678},{"date":"2025-06-06","current":-5.92871,"twenty":-15.126544,"median":-10.582949,"eighty":-5.698841,"marketCap":597210865},{"date":"2025-06-13","current":-6.15858,"twenty":-15.114854,"median":-10.503543,"eighty":-5.724382,"marketCap":620366052},{"date":"2025-06-20","current":-5.567944,"twenty":-15.086799,"median":-10.455018,"eighty":-5.687986,"marketCap":560870086},{"date":"2025-06-27","current":-5.788235,"twenty":-15.056571,"median":-10.424138,"eighty":-5.643102,"marketCap":583060473},{"date":"2025-07-03","current":-6.018104,"twenty":-15.025316,"median":-10.371201,"eighty":-5.641637,"marketCap":606215660},{"date":"2025-07-11","current":-6.580007,"twenty":-15.002134,"median":-10.30503,"eighty":-5.677131,"marketCap":662817229},{"date":"2025-07-18","current":-6.496998,"twenty":-14.98745,"median":-10.28959,"eighty":-5.714166,"marketCap":654455633},{"date":"2025-07-25","current":-6.956737,"twenty":-14.950568,"median":-10.234448,"eighty":-5.730129,"marketCap":700766007},{"date":"2025-08-01","current":-6.599162,"twenty":-14.912021,"median":-10.163866,"eighty":-5.73396,"marketCap":664746827},{"date":"2025-08-08","current":-6.113883,"twenty":-14.897039,"median":-10.14622,"eighty":-5.764609,"marketCap":615863655},{"date":"2025-08-15","current":-5.680098,"twenty":-14.891675,"median":-10.102106,"eighty":-5.714166,"marketCap":651813986},{"date":"2025-08-22","current":-6.633794,"twenty":-14.884329,"median":-10.031524,"eighty":-5.730129,"marketCap":761254359},{"date":"2025-08-29","current":-6.959172,"twenty":-14.857999,"median":-9.84404,"eighty":-5.73396,"marketCap":798592839},{"date":"2025-09-05","current":-6.917097,"twenty":-14.83641,"median":-9.826394,"eighty":-5.754393,"marketCap":793764587},{"date":"2025-09-09","current":-8.919858,"twenty":-14.830195,"median":-9.797719,"eighty":-5.774826,"marketCap":1023589371}],"updateTime":1757503226326},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DNTH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2566623009","title":"BRIEF-Dianthus Therapeutics Announces Pricing Of Upsized $251 Million Underwritten Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2566623009","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566623009?lang=en_us&edition=fundamental","pubTime":"2025-09-10 10:37","pubTimestamp":1757471843,"startTime":"0","endTime":"0","summary":"BRIEF-Dianthus Therapeutics Announces Pricing Of Upsized $251 Million Underwritten Public OfferingSept 9 (Reuters) - Dianthus Therapeutics Inc DNTH.O:DIANTHUS THERAPEUTICS, INC. ANNOUNCES PRICING OF U","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nTUA4XDVSS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2566160614","title":"BUZZ-Dianthus Therapeutics surges again ahead of planned equity raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2566160614","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566160614?lang=en_us&edition=fundamental","pubTime":"2025-09-10 01:17","pubTimestamp":1757438252,"startTime":"0","endTime":"0","summary":"**  Dianthus Therapeutics' DNTH.O shares surge 13.2% on Tues to $36, highest since Apr 2022, adding to strong gain in previous session. ** DNTH shares on Mon finished up 20% after co's mid-stage trial win for its muscle-weakening drug claseprubart. ** After the bell Mon, co commenced $150 mln stock offering to fund preclinical and clinical development activities, and for working capital and general purposes. ** Jefferies, TD Cowen, Evercore and Stifel are joint bookrunners for the offering. ** Dianthus has ~32.19 mln shares outstanding for about $1.2 bln current market cap. ** Raymond James early Tues hiked its PT by $7 to $63. ** All 13 brokerages covering DNTH are bullish with \"strongbuy\" avg rating; median PT is $51.50, per LSEG data. ** With the move on the session, shares up ~90% over the past three months, putting them up ~65% YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nL6N3UW0UY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","LU1363072403.SGD","RJF","IE00B64PRP62.GBP","BK4588","IE00BGHQF748.EUR","LU1804176565.USD","EVR","BK4585","BK4139","LU2265009873.SGD","DNTH","IE00B3QW5Z07.USD","LU0971096721.USD"],"gpt_icon":0},{"id":"2566949606","title":"Dianthus Therapeutics Is Maintained at Outperform by Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2566949606","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566949606?lang=en_us&edition=fundamental","pubTime":"2025-09-09 19:50","pubTimestamp":1757418600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DNTH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 09, 2025 07:50 ET (11:50 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","DNTH"],"gpt_icon":0},{"id":"2566691875","title":"Dianthus price target raised to $67 from $50 at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2566691875","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566691875?lang=en_us&edition=fundamental","pubTime":"2025-09-09 19:16","pubTimestamp":1757416586,"startTime":"0","endTime":"0","summary":"Baird raised the firm’s price target on Dianthus (DNTH) to $67 from $50 and keeps an Outperform rating on the shares. The firm said they are positi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dianthus-price-target-raised-to-67-from-50-at-baird-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dianthus-price-target-raised-to-67-from-50-at-baird-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2566323676","title":"Dianthus announces $150M common stock offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2566323676","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566323676?lang=en_us&edition=fundamental","pubTime":"2025-09-09 04:05","pubTimestamp":1757361920,"startTime":"0","endTime":"0","summary":"Dianthus (DNTH) Therapeutics announced that it has commenced an underwritten public offering of $150M of its shares of its common stock or, in lieu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dianthus-announces-150m-common-stock-offering-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dianthus-announces-150m-common-stock-offering-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2566063415","title":"Dianthus Therapeutics Inc. Announces $150 Million Underwritten Public Offering to Advance Antibody Therapeutics Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2566063415","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566063415?lang=en_us&edition=fundamental","pubTime":"2025-09-09 04:00","pubTimestamp":1757361613,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Inc., a clinical-stage biotechnology company focused on developing antibody complement therapeutics for severe autoimmune diseases, has announced a proposed $150 million underwritten public offering. The offering consists of shares of its common stock, with an option for certain investors to choose pre-funded warrants instead. Additionally, the company may grant underwriters a 30-day option to purchase up to an additional $22.5 million of common stock. The offering is subject to market conditions, and Dianthus plans to use the net proceeds to support its preclinical and clinical development activities, as well as for general corporate purposes. Jefferies, TD Cowen, Evercore ISI, and Stifel are serving as joint book-running managers for the offering. The offering will be conducted under an effective shelf registration statement filed with the SEC.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT str","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nNDL1ybFfD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","SF","BK4127","IE00B64PRP62.GBP","BK4588","LU2210149790.SGD","LU2210150020.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","NDAQ","LU0314104364.USD","DNTH","IE00B3QW5Z07.USD","BK4139","BK4585","EVR","BK4112"],"gpt_icon":0},{"id":"2566341456","title":"Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2566341456","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566341456?lang=en_us&edition=fundamental","pubTime":"2025-09-09 04:00","pubTimestamp":1757361601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nTUA4F9YFH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2566638072","title":"Dianthus Shares Whipsaw on Strong Trial Results, Safety Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2566638072","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566638072?lang=en_us&edition=fundamental","pubTime":"2025-09-08 23:58","pubTimestamp":1757347080,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics' stock whipsawed Monday after the biotech company reported data from a mid-stage trial of its treatment for generalized myasthenia gravis, an autoimmune disease.Shares surged in premarket trading as the drug, claseprubart, demonstrated strong efficacy in the Phase 2 trial, but they reversed course after investors zeroed in on potential safety concerns during a call with executives.Analysts said shares have since rebounded as investors digested the totality of the data. They were recently trading 18% higher at $31.20, extending their 34% gain year-to-date.Dianthus said before the bell that claseprubart met all primary and secondary endpoints in the trial, showing statistically significant and clinically meaningful improvements compared with placebo. The benefits are comparable to AstraZeneca's blockbuster drugs Ultomiris and Soliris, which together generate more than $2 billion annually as treatments for generalized myasthenia gravis, analysts said.\"That's what inv","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","BK4007","AZN","LU1829250122.USD","LU2236285917.USD","DNTH","LU0109394709.USD","LU2417539215.USD","LU2462157665.USD","BK4139","BK4585","BK4588","LU0889565916.HKD","BK4568","LU2456880835.USD"],"gpt_icon":0},{"id":"2566963367","title":"BUZZ-U.S. STOCKS ON THE MOVE-Sanofi SA, Nutanix, Bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2566963367","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566963367?lang=en_us&edition=fundamental","pubTime":"2025-09-08 23:53","pubTimestamp":1757346833,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Sanofi SA, Nutanix, BullishEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nL6N3UV0QZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0724618433.USD","LU2065171402.SGD","CNF","LU1366333091.USD","SATS","BK4198","NFE","SOS","VEEV","CMCSA","IE00BVYPNV92.GBP","IDYA","BLSH","LU0321505868.SGD","LU1852331112.SGD","DQ","NEM","KGS","NTNX","IPDN","NCLH","PLSE","LU2420271590.USD","GEV","LU1978683503.SGD","LU1934455194.USD","DNTH","LVWR","VZ","LU0738911758.USD","EPAM","RAPP","WIX","ECL","KDP","LU0320765646.SGD","SBAC","SOLV","002383","ALB","LU0225283273.USD","KRKR","T","LDI","TMUS","LU0058720904.USD","PL"],"gpt_icon":1},{"id":"2565863875","title":"Dianthus Therapeutics Shares Reverse Course, Last up 19.3% After Mid-Stage Trial Data for Its Muscle-Weakening Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2565863875","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565863875?lang=en_us&edition=fundamental","pubTime":"2025-09-08 23:45","pubTimestamp":1757346329,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nFWN3UV16O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2565876256","title":"Evercore ISI Adjusts Dianthus Therapeutics Price Target to $72 From $50, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2565876256","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565876256?lang=en_us&edition=fundamental","pubTime":"2025-09-08 22:05","pubTimestamp":1757340344,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics (DNTH) has an average rating of Buy and mean price target of $52.16, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","DNTH"],"gpt_icon":0},{"id":"2565687565","title":"Dianthus price target raised to $72 at Evercore after ‘bull case outcome’","url":"https://stock-news.laohu8.com/highlight/detail?id=2565687565","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565687565?lang=en_us&edition=fundamental","pubTime":"2025-09-08 21:40","pubTimestamp":1757338829,"startTime":"0","endTime":"0","summary":"Evercore ISI raised the firm’s price target on Dianthus (DNTH) to $72 from $50 and keeps an Outperform rating on the shares after both doses “clear...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dianthus-price-target-raised-to-72-at-evercore-after-bull-case-outcome-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dianthus-price-target-raised-to-72-at-evercore-after-bull-case-outcome-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2565688682","title":"Dianthus Therapeutics Shares Reverse Premarket Gains, Last Down 13.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565688682","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565688682?lang=en_us&edition=fundamental","pubTime":"2025-09-08 21:33","pubTimestamp":1757338407,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nFWN3UV1GZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2565685054","title":"BUZZ-U.S. STOCKS ON THE MOVE-Veeva, Gold miners, Ideaya Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2565685054","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565685054?lang=en_us&edition=fundamental","pubTime":"2025-09-08 19:37","pubTimestamp":1757331443,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Veeva, Gold miners, Ideaya BiosciencesEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nL6N3UV0JC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B894F039.SGD","LU0456854461.SGD","LU1430597077.USD","LU0390135506.SGD","BK4089","BK4526","NEM","BK4519","BK4534","RAPP","LU0368265764.SGD","LU0788108826.HKD","DNTH","IE00B19Z9P08.USD","NFE","BK4532","BK4147","IE00B19Z9Z06.USD","LU0055631609.USD","LU0498741114.HKD","LU1280957306.USD","IDYA","LU0612318971.USD","BK4588","LU1223082196.USD","LU0390135332.USD","LU0788109121.HKD","VEEV","BK4144","LU0278409577.USD","LU0654597011.USD","LU0390135688.USD","DQ","LU0266512127.USD","LU0724618789.USD","LU1861559042.SGD","BK4167","BK4139","LU2498475776.HKD","SATS","BK4613","LU1223082519.USD","BK4138","BK4585","LU0300738605.USD","LU0289739699.SGD","BK4570","BK4127"],"gpt_icon":1},{"id":"2565685150","title":"BUZZ-Dianthus Therapeutics rises after mid-stage trial win for muscle-weakening drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2565685150","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565685150?lang=en_us&edition=fundamental","pubTime":"2025-09-08 19:25","pubTimestamp":1757330751,"startTime":"0","endTime":"0","summary":"BUZZ-Dianthus Therapeutics rises after mid-stage trial win for muscle-weakeningdrug** Shares of drug developer Dianthus Therapeutics DNTH.O rise 17% to $31 premarket** DNTH's experimental drug clasepr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nL6N3UV0J1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2565685302","title":"Dianthus announces data from Phase 2 MaGic trial of claseprubart","url":"https://stock-news.laohu8.com/highlight/detail?id=2565685302","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565685302?lang=en_us&edition=fundamental","pubTime":"2025-09-08 19:15","pubTimestamp":1757330152,"startTime":"0","endTime":"0","summary":"Dianthus (DNTH) Therapeutics announced top-line data from the Phase 2 MaGic trial evaluating the safety and efficacy of claseprubart in adults with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dianthus-announces-data-from-phase-2-magic-trial-of-claseprubart-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dianthus-announces-data-from-phase-2-magic-trial-of-claseprubart-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2565683485","title":"Dianthus Therapeutics Inc - Claseprubart Shows Favorable Safety Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2565683485","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565683485?lang=en_us&edition=fundamental","pubTime":"2025-09-08 19:00","pubTimestamp":1757329201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nTUA6VZWDW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2565120683","title":"Dianthus Therapeutics Inc - Phase 3 Gmg Trial for Claseprubart Anticipated to Start in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2565120683","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565120683?lang=en_us&edition=fundamental","pubTime":"2025-09-08 19:00","pubTimestamp":1757329201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nTUA6VZWDW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2565203625","title":"Dianthus Therapeutics Inc. Announces Phase 2 MaGic Trial Results for Claseprubart (DNTH103) in Generalized Myasthenia Gravis","url":"https://stock-news.laohu8.com/highlight/detail?id=2565203625","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565203625?lang=en_us&edition=fundamental","pubTime":"2025-09-08 06:25","pubTimestamp":1757283911,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Inc. has announced that it will host a conference call and webcast to discuss the results from its Phase 2 MaGic trial of claseprubart  in generalized Myasthenia Gravis. The event is scheduled for Monday, September 8, 2025, at 8:00 a.m. EDT. Participants interested in joining the live conference call can register to receive the dial-in number and personal PIN. The webcast will be accessible through the Investors and Media section of the company's website. A replay of the call will be available after the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on September 07, 2025, and is solely responsible f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250907:nNDL87zC46:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","BK4139","IE00BGHQF748.EUR","LU0314104364.USD","BK4585","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4112","DNTH","LU2210149790.SGD","NDAQ","LU2095319765.USD","BK4588","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2565459605","title":"Dianthus Therapeutics (DNTH) Gets a Buy from Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2565459605","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565459605?lang=en_us&edition=fundamental","pubTime":"2025-09-06 05:45","pubTimestamp":1757108709,"startTime":"0","endTime":"0","summary":"In a report released today, Yatin Suneja from Guggenheim reiterated a Buy rating on Dianthus Therapeutics, with a price target of $92.00. The compa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/dianthus-therapeutics-dnth-gets-a-buy-from-guggenheim-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/dianthus-therapeutics-dnth-gets-a-buy-from-guggenheim-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","DNTH"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":41,"code":"91000000","status":"200"}]}}